The Neuroscience 2023 meeeting takes place in Washington D.C. on November 11-15. During the conference, we will present several posters covering some of the exciting research that we and our partners are conducting. We invite you to attend the poster presentations or to contact us to arrange a meeting with the onsite Cellectricon team.

Recommended posters:

 

Visit event site

The 6th Neuropsychiatric Drug Development Summit takes place in Boston, US on October 10-12. The meeting focuses on the advancement in drug discovery for neuropsychiatric disorders, covering both new development in non-psychedelic and psychedelic R&D – from discovery to clinical advancements.

As a leading provider of neurobiology in vitro research services, Cellectricon is proud to be a partner of the summit. We are very much looking forward to joining other industry experts in the discussion on approaches for developing and advancing transformative candidates through the clinic.

At the meeting, Paul Karila, Head of Drug Discovery at Cellectricon, will give a presentation on October 11:

In Vitro Drug Discovery Strategies for Neuropsychiatric Disorders

  • From neurite to network level – applying neuroplasticity in vitro models for Drug Discovery
  • Combining high content imaging and functional methods
  • Addressing challenges of low throughput and high variability

If you are interested in learning more about the Neuroplasticity Service Module or Cellectricon’s drug discovery services, please reach out to us.

Visit event site

BioJapan takes place in Yokohama, Japan on October 11-13, 2023. The meeting is held in parallel with Regenerative Medicine JAPAN and health TECH JAPAN and is Asia’s largest partnering event, providing the opportunity for pharmaceutical companies and biotechs to connect with representatives from academia and CROs.

If you are interested in learning more about Cellectricon’s drug discovery services and connecting at the conference, reach out to setup a meeting.

Visit event site

Discovery Europe and the Neuroscience Drug Development Europe meetings take place in parallel in Berlin, Germany on June 6-7, 2023.

Cellectricon is a proud sponsor of this summit that brings together leading experts from the drug discovery community to discuss emerging strategies for neuroscience drug development, as well as the latest advancements in target identification, validation and hit optimization.

If you are interested in learning more about Cellectricon’s neuroscience drug discovery services, reach out to setup a meeting with our onsite team.

 

Visit event site

The Neuro4D conference takes place in Mainz, Germany on May 15-16, 2023.

With a focus on drug discovery for proteopathic neurodegenerative diseases, the meeting brings together experts from discovery companies, service providers and academic innovators in the field of neurodegenerative diseases e.g. Alzheimer’s disease, Parkinson’s disease, FTD and ALS.

At the meeting, Lotta Agholme, Laboratory Operations Manager at Cellectricon, will give a presentation on:

Effects of partial reduction of amyloid-β production on synaptic function in vitro

 

If you are interested in learning more about the talk or Cellectricon’s drug discovery services, please reach out to us.

Visit event site

The AD/PD 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders takes place in Gothenburg, Sweden on March 28 – April 1, 2023.

Take the opportunity to connect with the Cellectricon team at the meeting and attend our poster presentations:

To receive a copy of the posters and to learn more about Cellectricon’s services for neurodegenerative disease drug discovery we invite you to reach out to us.

Visit event site

We’re excited to be working with Delix Therapeutics and support their development of neuroplasticity-promoting therapeutics!
At Cellectricon, we solve our Clients’ scientific challenges through innovative approaches for in vitro research. This includes the creation of novel high content imaging assays for measuring effects on structural and functional neuroplasticity in vitro.

If you are curious to learn more about how we can support your drug discovery project, please get in touch.

Click here to read the full press release.

Cellectricon AB, a leading provider of neurobiology in vitro research services, today announced that the company received notice of intention to grant a patent from the European Patent Office (EPO). The granting of the company’s patent application No. 14 162 861, titled “Apparatus and method for tip alignment in multiwell plates”, adds to Cellectricon’s deep intellectual property portfolio focused on technologies for cell-based assays.

The patent was developed and authored by Chief Operating Officer, Dr. Johan Pihl, and Chief Executive Officer, Dr. Mathias Karlsson. The patent is focused on solutions for enabling the usage of high-density microtiter plate formats in cell-based assays. Currently, the invention is being utilized in Cellectricon’s proprietary optical electrophysiology platform. “Our Company has a successful track record of developing state-of-the-art technologies for cell-based assay research. Our goal is to continue to build on this platform and bring the next wave of evolution in in vitro neurobiology to our Clients”, said Mathias Karlsson.

Cellectricon provides neurobiology in vitro research services for Clients looking to understand disease mechanisms and conduct drug discovery campaigns to identify novel targets and lead compounds. The company’s mission is to create groundbreaking in vitro concepts that will advance the neuroscience research field and enable their Clients to conduct successful drug discovery programs.

For more information on Cellectricon, please visit www.cellectricon.com

The Neuroscience 2022 meeeting takes place in San Diego on November 12-16. During the conference, we will present several posters covering some of the exciting research that we and our partners are conducting. We invite you to attend the poster presentations or to meet with the Cellectricon team in stand 536 in the exhibit hall.

Recommended posters:

Visit event site